K022992

Substantially Equivalent

REAADS ANTI-CARDIOLIPIN IGG/IGM SEMI-QUANTITATIVE TEST KIT, MODEL 023-001

Applicant: Corgenix, Inc.
Product code: MID
Advisory panel: Immunology
Date received: 2002-09-09
Decision date: 2002-09-25
Decision: Substantially Equivalent
Clearance type: Special
Location: Westminster, CO, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.